Cascades Capital Asset Management, LLC Amgen Inc Transaction History
Cascades Capital Asset Management, LLC
- $182 Billion
- Q3 2024
A detailed history of Cascades Capital Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cascades Capital Asset Management, LLC holds 2,114 shares of AMGN stock, worth $625,596. This represents 0.38% of its overall portfolio holdings.
Number of Shares
2,114Holding current value
$625,596% of portfolio
0.38%Shares
1 transactions
Others Institutions Holding AMGN
# of Institutions
3,113Shares Held
410MCall Options Held
7MPut Options Held
6.15M-
Vanguard Group Inc Valley Forge, PA52.4MShares$15.5 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.68 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.35 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.22 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $158B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...